In-Depth With CDRH Compliance Chief: Jan Welch Trumpets 'Case For Quality,' Urges Feedback From Manufacturers
This article was originally published in The Gray Sheet
This "Silver Sheet"/"Gray Sheet" Q&A with Jan Welch, interim director of CDRH's Office of Compliance, offers a glimpse into current device center thinking on various activities such as FDA's "Case for Quality." She also warns device manufacturers that if they don't speak up, some issues of importance to them could end up on the back burner. And: Is Welch interested in the job full time?
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.